Bristol-Myers Squibb recalls Coumadin
Bristol-Myers Squibb Co. said Monday it is recalling eight production lots of its anti-clotting drug Coumadin because the amount of the active ingredient in the drug could change.
A blood thinner that has been linked to 19 deaths in the United States is now being recalled in Canada after a contaminant was found in products made by a specific manufacturer, Health Canada said yesterday.